With a market cap of $202.2 billion, North Chicago, Illinois-based Abbott Laboratories (ABT) is a global healthcare company.

Abbott Laboratories and a unit of Reckitt Benckiser Group Plc were cleared by a jury over claims they hid risks their ...

CNBC’s Jim Cramer on Friday evaluated the stock of Abbott Laboratories, a healthcare company that’s been weighed down by ...

A St. Louis jury handed Abbott Laboratories a win Thursday, deciding that Abbott, another company and a hospital were not ...

Shares in Reckitt Benckiser topped the Stoxx Europe 600 Index after a U.S. court cleared the company of liability in a case ...

Shares of Abbott Laboratories ABT rose 4.61% to $118.60 Friday, on what proved to be an all-around positive trading session ...

In closing arguments on Wednesday, plaintiff's lawyer Timothy Cronin asked jurors for $6 billion in punitive damages.

Abbott Laboratories (NYSE:ABT) rose 6% in after hours trading after a jury found the company and a Reckitt Benckiser ...

Abbott Laboratories traded as high as $118.00 and last traded at $117.67. 598,605 shares were traded during trading, a decline of 90% from the average session volume of 5,703,130 shares. The stock ...

Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), The Procter & ...

In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against the other pharma stocks. Healthcare takes the concept of 'defensive' further than almost any ...